eMurmur ID vs iPredict Eye Screening
AI Verdict
Choose eMurmur ID if…
Choose eMurmur ID if your practice requires an AI-powered solution for real-time detection and classification of heart murmurs. This tool is ideal for clinicians in cardiology, family medicine, or pediatrics who need immediate decision support when analyzing heart sounds from third-party electronic stethoscopes, helping to quickly identify pathologic or innocent murmurs.
View eMurmur ID →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if you need a comprehensive, AI-driven platform for early detection of multiple retinal diseases, including AMD, Diabetic Retinopathy, and Glaucoma. This tool is best suited for primary care settings or ophthalmology clinics looking for a fast, non-invasive screening method that also provides risk prediction for systemic conditions like stroke and heart attack.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | eMurmur ID | iPredict Eye Screening |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud, Mobile, API integration | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
iPredict Eye ScreeningTool B (iPredict Eye Screening) emphasizes an 'easy to operate, non-invasive, with an advanced touchscreen interface' and delivers 'fast results: test completed in less than 5 minutes, report in under 60 seconds.' While Tool A (eMurmur ID) also offers real-time feedback and a mobile app, its reliance on a third-party electronic stethoscope might introduce more variability in the user experience compared to Tool B's seemingly more integrated and rapid screening process.
Clinical Value
iPredict Eye ScreeningTool B (iPredict Eye Screening) offers a broader clinical scope, screening for multiple critical eye conditions (Diabetic Retinopathy, AMD, Glaucoma) and providing risk prediction for systemic diseases like stroke and heart attack. It also explicitly states high accuracy metrics (e.g., AMD sensitivity 86.86%, specificity 94.13%) from prospective trials. Tool A (eMurmur ID) focuses on heart murmur detection and classification, providing valuable decision support, but with a narrower range of conditions.
Pricing & Value
iPredict Eye ScreeningTool B (iPredict Eye Screening) provides a transparent pricing model, estimating $10-$20 per patient screening on a SaaS model, which is tied to Medicare/commercial payor reimbursement. This offers a clear understanding of potential costs and return on investment. Tool A (eMurmur ID) only states 'contact vendor' for pricing information, offering no immediate transparency.
Enterprise Readiness
eMurmur IDTool A (eMurmur ID) explicitly states it is HIPAA compliant, FDA cleared, and has a Business Associate Agreement (BAA) in place. It also offers flexible deployment options including mobile, cloud, on-premise, and hybrid. While Tool B (iPredict Eye Screening) is HIPAA compliant and FDA cleared, it does not explicitly state having a BAA, which is a critical component for enterprise deployments handling protected health information.
Innovation
iPredict Eye ScreeningTool B (iPredict Eye Screening) demonstrates greater innovation by offering AI-powered screening for multiple retinal diseases and extending to systemic disease risk prediction (stroke, heart attack), integrating with EHR and telemedicine services. This comprehensive approach to preventative care across different disease categories is a significant advancement. Tool A (eMurmur ID) innovates in heart murmur detection using AI with third-party stethoscopes, but its scope is more focused.
Support & Docs
TieNeither the provided structured facts nor the web search results offer sufficient specific information regarding the quality, availability, or comprehensiveness of support and documentation for either Tool A (eMurmur ID) or Tool B (iPredict Eye Screening). Therefore, it is not possible to definitively pick a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | eMurmur ID | iPredict Eye Screening |
|---|---|---|
| Product Name | eMurmur ID | iPredict Eye Screening |
| Company | CSD Labs GmbH | iHealthScreen |
| Description | AI-powered mobile and cloud solution for detecting and classifying heart murmurs using a third-party electronic stethoscope, providing decision support for healthcare providers. | iHealthScreen offers an FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. |
| Primary Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Neurology AI, Ophthalmology AI |
| Key Features (Selection) | AI-based analytics for heart murmur detection and classification, Mobile app for recording and displaying heart sounds, Operates with 3rd party electronic stethoscopes | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, Electronic Health Record (EHR) Solutions, Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients |
Videos
Demos, reviews, and walkthroughs featuring eMurmur ID and iPredict Eye Screening.